Liposomal transfection efficiency and toxicity on glioma cell lines:: in vitro and in vivo studies

被引:34
作者
Bell, H [1 ]
Kimber, WL [1 ]
Li, MW [1 ]
Whittle, IR [1 ]
机构
[1] Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland
关键词
gene transfer; glioma; liposome; neurotoxicity;
D O I
10.1097/00001756-199803300-00005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
To evaluate the influence of cell type and cationic liposomal formulation on gene transfection efficiency three liposomes (lipofectin, lipofectamine and DOTAP) were used to transfect the human (A172 and MOG-G-CCM) and rodent (C6 and A15A5) glioma cell lines with the Lac Z gene. Parallel studies evaluated in vitro cytotoxicity and the neuropathological changes following intracerebral injection. The transfection efficiency and cytotoxicity of the liposomes varied both quantitatively and qualitatively between the cell lines. There were no behavioural disturbances following intrastriatal or hippocampal injection and the neuropathological changes at the injection sites were focal and similar for all liposomes. The influence of glial cell lineage on both liposomal transfection facility and cytotoxicity may have important implications for in vivo gene transfection in the central nervous system. (C) 1998 Rapid Science Ltd.
引用
收藏
页码:793 / 798
页数:6
相关论文
共 18 条
  • [1] LIPOSOME TOXICITY IN MOUSE CENTRAL NERVOUS-SYSTEM
    ADAMS, DH
    JOYCE, G
    RICHARDSON, VJ
    RYMAN, BE
    WISNIEWSKI, HM
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1977, 31 (02) : 173 - 179
  • [2] Bebok Z, 1996, J PHARMACOL EXP THER, V279, P1462
  • [3] CAPLEN NJ, 1995, GENE THER, V2, P603
  • [4] FELGNER JH, 1994, J BIOL CHEM, V269, P2550
  • [5] MODE OF FORMATION AND STRUCTURAL FEATURES OF DNA CATIONIC LIPOSOME COMPLEXES USED FOR TRANSFECTION
    GERSHON, H
    GHIRLANDO, R
    GUTTMAN, SB
    MINSKY, A
    [J]. BIOCHEMISTRY, 1993, 32 (28) : 7143 - 7151
  • [6] HARADA K, 1995, J SURG ONCOL, V59, P105
  • [7] HARRISON GS, 1995, BIOTECHNIQUES, V19, P816
  • [8] Kitamura I, 1996, CANCER RES, V56, P3986
  • [9] Reszka R, 1995, J LIPOS RES, V5, P149, DOI 10.3109/08982109509039915
  • [10] RYMAN BE, 1975, CLIN PHARM, V5, P91